Pharma can’t afford to sit out of social media — but showing up comes with real responsibility.
In this article, Mike Dixon, HCA CEO, explores why engagement is no longer optional for pharmaceutical companies, not just for brand visibility, but to counter misinformation with evidence-based voices. The challenge? Navigating a fast-moving social landscape where compliance, ambiguity and risk sit alongside opportunity.
From the clear no-fly zone of POM promotion, to the nuance of disease awareness, influencers, hashtags and employee activity, this article in Decembers issue of PME offers practical guidance grounded in real-world experience. It also highlights how updated industry codes, and the HCA’s new social media guide are helping teams move from fear-based avoidance to confident, compliant participation.
A timely read for anyone shaping pharma content in public spaces, where doing good and doing it right must go hand in hand.
👉 Read the full article here: [https://bit.ly/4jW2qNO]